Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 9, Number 11—November 2003

Volume 9, Number 11—November 2003   PDF Version [PDF - 16.17 MB - 151 pages]

Perspective

  • Risks and Benefits of Preexposure and Postexposure Smallpox Vaccination PDF Version [PDF - 700 KB - 8 pages]
    M. I. Meltzer
        View Abstract

    This article presents a model and decision criteria for evaluating a person’s risk of pre- or postexposure smallpox vaccination in light of serious vaccine-related adverse events (death, postvaccine encephalitis and progressive vaccinia). Even at a 1-in-10 risk of 1,000 initial smallpox cases, a person in a population of 280 million has a greater risk for serious vaccine-related adverse events than a risk for smallpox. For a healthcare worker to accept preexposure vaccination, the risk for contact with an infectious smallpox case-patient must be >1 in 100, and the probability of 1,000 initial cases must be >1 in 1,000. A member of an investigation team would accept preexposure vaccination if his or her anticipated risk of contact is 1 in 2.5 and the risk of attack is assumed to be >1 in 16,000. The only circumstances in which postexposure vaccination would not be accepted are the following: if vaccine efficacy were <1%, the risk of transmission were <1%, and (simultaneously) the risk for serious vaccine-related adverse events were >1 in 5,000.

        Cite This Article
    EID Meltzer MI. Risks and Benefits of Preexposure and Postexposure Smallpox Vaccination. Emerg Infect Dis. 2003;9(11):1363-1370. https://dx.doi.org/10.3201/eid0911.030369
    AMA Meltzer MI. Risks and Benefits of Preexposure and Postexposure Smallpox Vaccination. Emerging Infectious Diseases. 2003;9(11):1363-1370. doi:10.3201/eid0911.030369.
    APA Meltzer, M. I. (2003). Risks and Benefits of Preexposure and Postexposure Smallpox Vaccination. Emerging Infectious Diseases, 9(11), 1363-1370. https://dx.doi.org/10.3201/eid0911.030369.

Synopses

  • Toxoplasma gondii Infection in the United States, 1999–2000 PDF Version [PDF - 183 KB - 4 pages]
    J. L. Jones et al.
        View Abstract

    Infection with Toxoplasma gondii can lead to congenital and acquired disease, resulting in loss of vision and neurologic illness. We tested sera collected in the National Health and Examination Survey (NHANES) from 1999–2000 for T. gondii–specific immunoglobulin G antibodies and compared these results with results from sera obtained in the NHANES III survey (1988–1994). NHANES collects data on a nationally representative sample of the U.S. civilian population. Of 4,234 persons 12–49 years of age in NHANES 1999–2000, 15.8% (age-adjusted, 95% confidence limits [CL] 13.5, 18.1) were antibody positive; among women (n=2,221) 14.9% (age-adjusted, 95% CL 12.5, 17.4) were antibody positive. T. gondii antibody prevalence was higher among non-Hispanic black persons than among non-Hispanic white persons (age-adjusted prevalence 19.2% vs. 12.1%, p=0.003) and increased with age. No statistically significant differences were found between T. gondii antibody prevalence in NHANES 1999–2000, and NHANES III. T. gondii antibody prevalence has remained stable over the past 10 years in the United States.

        Cite This Article
    EID Jones JL, Kruszon-Moran D, Wilson M. Toxoplasma gondii Infection in the United States, 1999–2000. Emerg Infect Dis. 2003;9(11):1371-1374. https://dx.doi.org/10.3201/eid0911.030098
    AMA Jones JL, Kruszon-Moran D, Wilson M. Toxoplasma gondii Infection in the United States, 1999–2000. Emerging Infectious Diseases. 2003;9(11):1371-1374. doi:10.3201/eid0911.030098.
    APA Jones, J. L., Kruszon-Moran, D., & Wilson, M. (2003). Toxoplasma gondii Infection in the United States, 1999–2000. Emerging Infectious Diseases, 9(11), 1371-1374. https://dx.doi.org/10.3201/eid0911.030098.
  • Toxoplasma gondii and Schizophrenia PDF Version [PDF - 370 KB - 6 pages]
    E. F. Torrey and R. H. Yolken
        View Abstract

    Recent epidemiologic studies indicate that infectious agents may contribute to some cases of schizophrenia. In animals, infection with Toxoplasma gondii can alter behavior and neurotransmitter function. In humans, acute infection with T. gondii can produce psychotic symptoms similar to those displayed by persons with schizophrenia. Since 1953, a total of 19 studies of T. gondii antibodies in persons with schizophrenia and other severe psychiatric disorders and in controls have been reported; 18 reported a higher percentage of antibodies in the affected persons; in 11 studies the difference was statistically significant. Two other studies found that exposure to cats in childhood was a risk factor for the development of schizophrenia. Some medications used to treat schizophrenia inhibit the replication of T. gondii in cell culture. Establishing the role of T. gondii in the etiopathogenesis of schizophrenia might lead to new medications for its prevention and treatment.

        Cite This Article
    EID Torrey EF, Yolken RH. Toxoplasma gondii and Schizophrenia. Emerg Infect Dis. 2003;9(11):1375-1380. https://dx.doi.org/10.3201/eid0911.030143
    AMA Torrey EF, Yolken RH. Toxoplasma gondii and Schizophrenia. Emerging Infectious Diseases. 2003;9(11):1375-1380. doi:10.3201/eid0911.030143.
    APA Torrey, E. F., & Yolken, R. H. (2003). Toxoplasma gondii and Schizophrenia. Emerging Infectious Diseases, 9(11), 1375-1380. https://dx.doi.org/10.3201/eid0911.030143.

Research

  • Coronavirus-positive Nasopharyngeal Aspirate as Predictor for Severe Acute Respiratory Syndrome Mortality
    O. T. Tsang et al.
        View Abstract

    Severe acute respiratory syndrome (SARS) has caused a major epidemic worldwide. A novel coronavirus is deemed to be the causative agent. Early diagnosis can be made with reverse transcriptase-polymerase chain reaction (RT-PCR) of nasopharyngeal aspirate samples. We compared symptoms of 156 SARS-positive and 62 SARS-negative patients in Hong Kong; SARS was confirmed by RT-PCR. The RT-PCR–positive patients had significantly more shortness of breath, a lower lymphocyte count, and a lower lactate dehydrogenase level; they were also more likely to have bilateral and multifocal chest radiograph involvement, to be admitted to intensive care, to need mechanical ventilation, and to have higher mortality rates. By multivariate analysis, positive RT-PCR on nasopharyngeal aspirate samples was an independent predictor of death within 30 days.

        Cite This Article
    EID Tsang OT, Chau T, Choi K, Tso EY, Lim W, Chiu M, et al. Coronavirus-positive Nasopharyngeal Aspirate as Predictor for Severe Acute Respiratory Syndrome Mortality. Emerg Infect Dis. 2003;9(11):1381-1387. https://dx.doi.org/10.3201/eid0911.030400
    AMA Tsang OT, Chau T, Choi K, et al. Coronavirus-positive Nasopharyngeal Aspirate as Predictor for Severe Acute Respiratory Syndrome Mortality. Emerging Infectious Diseases. 2003;9(11):1381-1387. doi:10.3201/eid0911.030400.
    APA Tsang, O. T., Chau, T., Choi, K., Tso, E. Y., Lim, W., Chiu, M....Lai, S. (2003). Coronavirus-positive Nasopharyngeal Aspirate as Predictor for Severe Acute Respiratory Syndrome Mortality. Emerging Infectious Diseases, 9(11), 1381-1387. https://dx.doi.org/10.3201/eid0911.030400.
  • West Nile Virus Infection in Nonhuman Primate Breeding Colony, Concurrent with Human Epidemic, Southern Louisiana PDF Version [PDF - 430 KB - 7 pages]
    M. S. Ratterree et al.
        View Abstract

    During the summer of 2002, an epidemic of West Nile meningoencephalitis occurred in southern Louisiana. Following the outbreak, blood samples were collected from 1,692 captive rhesus monkeys (Macaca mulatta), pigtail macaques (M. nemestrina), and baboons (Papio spp.) that were permanently housed outdoors at a nonhuman primate breeding facility in St. Tammany Parish, Louisiana. The serum samples were examined for antibodies to West Nile virus (WNV). Overall, 36% of the captive nonhuman primates had WNV antibodies; comparison of these samples with banked serum samples from previous blood collections indicated that the animals were infected subclinically from February to August 2002. WNV activity was demonstrated in surveillance at the nonhuman primate-breeding colony and in the neighboring community during this same period. The high infection rate in this captive nonhuman primate population illustrates the intensity of WNV transmission that can occur silently in nature among other susceptible vertebrates during epidemic periods.

        Cite This Article
    EID Ratterree MS, Travassos da Rosa A, Bohm RP, Cogswell FB, Phillippi KM, Caillouet K, et al. West Nile Virus Infection in Nonhuman Primate Breeding Colony, Concurrent with Human Epidemic, Southern Louisiana. Emerg Infect Dis. 2003;9(11):1388-1394. https://dx.doi.org/10.3201/eid0911.030226
    AMA Ratterree MS, Travassos da Rosa A, Bohm RP, et al. West Nile Virus Infection in Nonhuman Primate Breeding Colony, Concurrent with Human Epidemic, Southern Louisiana. Emerging Infectious Diseases. 2003;9(11):1388-1394. doi:10.3201/eid0911.030226.
    APA Ratterree, M. S., Travassos da Rosa, A., Bohm, R. P., Cogswell, F. B., Phillippi, K. M., Caillouet, K....Tesh, R. B. (2003). West Nile Virus Infection in Nonhuman Primate Breeding Colony, Concurrent with Human Epidemic, Southern Louisiana. Emerging Infectious Diseases, 9(11), 1388-1394. https://dx.doi.org/10.3201/eid0911.030226.
  • Human Hantavirus Infections, Sweden PDF Version [PDF - 669 KB - 6 pages]
    G. E. Olsson et al.
        View Abstract

    The prevalent human hantavirus disease in Sweden is nephropathia epidemica, which is caused by Puumala virus and shed by infected bank voles (Clethrionomys glareolus). To evaluate temporal and spatial patterns of this disease, we studied 2,468 reported cases from a highly disease-endemic region in northern Sweden. We found that, in particular, middle-aged men living in rural dwellings near coastal areas were overrepresented. The case-patients were most often infected in late autumn, when engaged in activities near or within manmade rodent refuges. Of 862 case-patients confident about the site of virus exposure, 50% were concentrated within 5% of the study area. The incidence of nephropathia epidemica was significantly correlated with bank vole numbers within monitored rodent populations in part of the region. Understanding this relationship may help forestall future human hantavirus outbreaks.

        Cite This Article
    EID Olsson GE, Dalerum F, Hörnfeldt B, Elgh F, Palo TR, Juto P, et al. Human Hantavirus Infections, Sweden. Emerg Infect Dis. 2003;9(11):1395-1401. https://dx.doi.org/10.3201/eid0911.030275
    AMA Olsson GE, Dalerum F, Hörnfeldt B, et al. Human Hantavirus Infections, Sweden. Emerging Infectious Diseases. 2003;9(11):1395-1401. doi:10.3201/eid0911.030275.
    APA Olsson, G. E., Dalerum, F., Hörnfeldt, B., Elgh, F., Palo, T. R., Juto, P....Ahlm, C. (2003). Human Hantavirus Infections, Sweden. Emerging Infectious Diseases, 9(11), 1395-1401. https://dx.doi.org/10.3201/eid0911.030275.
  • Fatal Spotted Fever Rickettsiosis, Minas Gerais, Brazil PDF Version [PDF - 252 KB - 4 pages]
    M. A. Galvão et al.
        View Abstract

    The emergence and reemergence of a serious infectious disease are often associated with a high case-fatality rate because of misdiagnosis and inappropriate or delayed treatment. The current reemergence of spotted fever rickettsiosis caused by Rickettsia rickettsii in Brazil has resulted in a high proportion of fatal cases. We describe two familial clusters of Brazilian spotted fever in the state of Minas Gerais, involving six children 9 months to 15 years of age; five died. Immunohistochemical investigation of tissues obtained at necropsy of a child in each location, Novo Cruzeiro and Coronel Fabriciano municipalities, established the diagnosis by demonstration of disseminated endothelial infection with spotted fever group rickettsiae. The diagnosis in the two fatal cases from Coronel Fabriciano and the surviving patient from Novo Cruzeiro was further supported by immunofluorescence serologic tests.

        Cite This Article
    EID Galvão MA, Dumler J, Mafra CL, Calic SB, Chamone CB, Filho GC, et al. Fatal Spotted Fever Rickettsiosis, Minas Gerais, Brazil. Emerg Infect Dis. 2003;9(11):1402-1405. https://dx.doi.org/10.3201/eid0911.030193
    AMA Galvão MA, Dumler J, Mafra CL, et al. Fatal Spotted Fever Rickettsiosis, Minas Gerais, Brazil. Emerging Infectious Diseases. 2003;9(11):1402-1405. doi:10.3201/eid0911.030193.
    APA Galvão, M. A., Dumler, J., Mafra, C. L., Calic, S. B., Chamone, C. B., Filho, G. C....Walker, D. H. (2003). Fatal Spotted Fever Rickettsiosis, Minas Gerais, Brazil. Emerging Infectious Diseases, 9(11), 1402-1405. https://dx.doi.org/10.3201/eid0911.030193.
  • Rapid Antigen-Capture Assay To Detect West Nile Virus in Dead Corvids PDF Version [PDF - 325 KB - 5 pages]
    R. Lindsay et al.
        View Abstract

    The utility of the VecTest antigen-capture assay to detect West Nile virus (WNV) in field-collected dead corvids was evaluated in Manitoba and Ontario, Canada, in 2001 and 2002. Swabs were taken from the oropharynx, cloaca, or both of 109 American Crows, 31 Blue Jays, 6 Common Ravens, and 4 Black-billed Magpies from Manitoba, and 255 American Crows and 28 Blue Jays from Ontario. The sensitivity and specificity of the antigen-capture assay were greatest for samples from American Crows; oropharyngeal swabs were more sensitive than cloacal swabs, and interlaboratory variation in the results was minimal. The sensitivity and specificity of the VecTest using oropharyngeal swabs from crows were 83.9% and 93.6%, respectively, for Manitoba samples and 83.3% and 95.8%, respectively, for Ontario birds. The VecTest antigen-capture assay on oropharyngeal secretions from crows is a reliable and rapid diagnostic test that appears suitable for incorporation into a WNV surveillance program.

        Cite This Article
    EID Lindsay R, Barker I, Nayar G, Drebot M, Calvin S, Scammell C, et al. Rapid Antigen-Capture Assay To Detect West Nile Virus in Dead Corvids. Emerg Infect Dis. 2003;9(11):1406-1410. https://dx.doi.org/10.3201/eid0911.030318
    AMA Lindsay R, Barker I, Nayar G, et al. Rapid Antigen-Capture Assay To Detect West Nile Virus in Dead Corvids. Emerging Infectious Diseases. 2003;9(11):1406-1410. doi:10.3201/eid0911.030318.
    APA Lindsay, R., Barker, I., Nayar, G., Drebot, M., Calvin, S., Scammell, C....Artsob, H. (2003). Rapid Antigen-Capture Assay To Detect West Nile Virus in Dead Corvids. Emerging Infectious Diseases, 9(11), 1406-1410. https://dx.doi.org/10.3201/eid0911.030318.
  • Serologic Evidence of Dengue Infection before Onset of Epidemic, Bangladesh PDF Version [PDF - 287 KB - 4 pages]
    M. Hossain et al.
        View Abstract

    Dengue fever emerged in Bangladesh in 2000. We tested 225 serum and plasma samples from febrile patients and 184 blood donors in 1996 and 1997 for dengue antibodies; 55 (24.4%) febrile patients had dengue antibodies (65.5% with secondary infection pattern), compared with one (0.54%) donor (p < 0.001), suggesting that dengue transmission was ongoing well before 1996.

        Cite This Article
    EID Hossain M, Khatun M, Arjumand F, Nisaluk A, Breiman RF. Serologic Evidence of Dengue Infection before Onset of Epidemic, Bangladesh. Emerg Infect Dis. 2003;9(11):1411-1414. https://dx.doi.org/10.3201/eid0911.030117
    AMA Hossain M, Khatun M, Arjumand F, et al. Serologic Evidence of Dengue Infection before Onset of Epidemic, Bangladesh. Emerging Infectious Diseases. 2003;9(11):1411-1414. doi:10.3201/eid0911.030117.
    APA Hossain, M., Khatun, M., Arjumand, F., Nisaluk, A., & Breiman, R. F. (2003). Serologic Evidence of Dengue Infection before Onset of Epidemic, Bangladesh. Emerging Infectious Diseases, 9(11), 1411-1414. https://dx.doi.org/10.3201/eid0911.030117.
  • Fluoroquinolones and the Risk for Methicillin-resistant Staphylococcus aureus in Hospitalized Patients
    S. G. Weber et al.
        View Abstract

    To determine whether fluoroquinolone exposure is a risk factor for the isolation of Staphylococcus aureus and whether the effect is different for methicillin-resistant S. aureus (MRSA) versus methicillin-susceptible S. aureus (MSSA), we studied two case groups. The first case group included 222 patients with nosocomially acquired MRSA. The second case group included 163 patients with nosocomially acquired MSSA. A total of 343 patients admitted concurrently served as controls. Outcome measures were the adjusted odds ratio (OR) for isolation of MRSA and MSSA after fluoroquinolone exposure. Exposure to both levofloxacin (OR 5.4; p < 0.0001) and ciprofloxacin (OR 2.2; p < 0.003) was associated with isolation of MRSA but not MSSA. After adjustment for multiple variables, both drugs remained risk factors for MRSA (levofloxacin OR 3.4; p < 0.0001; ciprofloxacin OR 2.5; p = 0.005) but not MSSA. Exposure to levofloxacin or ciprofloxacin is a significant risk factor for the isolation of MRSA, but not MSSA.

        Cite This Article
    EID Weber SG, Gold HS, Hooper DC, Karchmer A, Carmeli Y. Fluoroquinolones and the Risk for Methicillin-resistant Staphylococcus aureus in Hospitalized Patients. Emerg Infect Dis. 2003;9(11):1415-1422. https://dx.doi.org/10.3201/eid0911.030284
    AMA Weber SG, Gold HS, Hooper DC, et al. Fluoroquinolones and the Risk for Methicillin-resistant Staphylococcus aureus in Hospitalized Patients. Emerging Infectious Diseases. 2003;9(11):1415-1422. doi:10.3201/eid0911.030284.
    APA Weber, S. G., Gold, H. S., Hooper, D. C., Karchmer, A., & Carmeli, Y. (2003). Fluoroquinolones and the Risk for Methicillin-resistant Staphylococcus aureus in Hospitalized Patients. Emerging Infectious Diseases, 9(11), 1415-1422. https://dx.doi.org/10.3201/eid0911.030284.
  • Genetic Variation among Temporally and Geographically Distinct West Nile Virus Isolates, United States, 2001, 2002 PDF Version [PDF - 222 KB - 7 pages]
    C. Davis et al.
        View Abstract

    Analysis of partial nucleotide sequences of 22 West Nile virus (WNV) isolates collected during the summer and fall of 2001 and 2002 indicated genetic variation among strains circulating in geographically distinct regions of the United States and continued divergence from isolates collected in the northeastern United States during 1999 and 2000. Sequence analysis of a 2,004-nucleotide region showed that 14 isolates shared two nucleotide mutations and one amino acid substitution when they were compared with the prototype WN-NY99 strain, with 10 of these isolates sharing an additional nucleotide mutation. In comparison, isolates collected from coastal regions of southeast Texas shared the following differences from WN-NY99: five nucleotide mutations and one amino acid substitution. The maximum nucleotide divergence of the 22 isolates from WN-NY99 was 0.35% (mean = 0.18%). These results show the geographic clustering of genetically similar WNV isolates and the possible emergence of a dominant variant circulating across much of the United States during 2002.

        Cite This Article
    EID Davis C, Beasley D, Guzman H, Raj P, D’Anton M, Novak RJ, et al. Genetic Variation among Temporally and Geographically Distinct West Nile Virus Isolates, United States, 2001, 2002. Emerg Infect Dis. 2003;9(11):1423-1429. https://dx.doi.org/10.3201/eid0911.030301
    AMA Davis C, Beasley D, Guzman H, et al. Genetic Variation among Temporally and Geographically Distinct West Nile Virus Isolates, United States, 2001, 2002. Emerging Infectious Diseases. 2003;9(11):1423-1429. doi:10.3201/eid0911.030301.
    APA Davis, C., Beasley, D., Guzman, H., Raj, P., D’Anton, M., Novak, R. J....Barrett, A. (2003). Genetic Variation among Temporally and Geographically Distinct West Nile Virus Isolates, United States, 2001, 2002. Emerging Infectious Diseases, 9(11), 1423-1429. https://dx.doi.org/10.3201/eid0911.030301.
  • Ebola Hemorrhagic Fever Transmission and Risk Factors of Contacts, Uganda PDF Version [PDF - 254 KB - 8 pages]
    P. Francesconi et al.
        View Abstract

    From August 2000 through January 2001, a large epidemic of Ebola hemorrhagic fever occurred in Uganda, with 425 cases and 224 deaths. Starting from three laboratory-confirmed cases, we traced the chains of transmission for three generations, until we reached the primary case-patients (i.e., persons with an unidentified source of infection). We then prospectively identified the other contacts in whom the disease had developed. To identify the risk factors associated with transmission, we interviewed both healthy and ill contacts (or their proxies) who had been reported by the case-patients (or their proxies) and who met the criteria set for contact tracing during surveillance. The patterns of exposure of 24 case-patients and 65 healthy contacts were defined, and crude and adjusted prevalence proportion ratios (PPR) were estimated for different types of exposure. Contact with the patient’s body fluids (PPR = 4.61%, 95% confidence interval 1.73 to 12.29) was the strongest risk factor, although transmission through fomites also seems possible.

        Cite This Article
    EID Francesconi P, Yoti Z, Declich S, Onek PA, Fabiani M, Olango J, et al. Ebola Hemorrhagic Fever Transmission and Risk Factors of Contacts, Uganda. Emerg Infect Dis. 2003;9(11):1430-1437. https://dx.doi.org/10.3201/eid0911.030339
    AMA Francesconi P, Yoti Z, Declich S, et al. Ebola Hemorrhagic Fever Transmission and Risk Factors of Contacts, Uganda. Emerging Infectious Diseases. 2003;9(11):1430-1437. doi:10.3201/eid0911.030339.
    APA Francesconi, P., Yoti, Z., Declich, S., Onek, P. A., Fabiani, M., Olango, J....Salmaso, S. (2003). Ebola Hemorrhagic Fever Transmission and Risk Factors of Contacts, Uganda. Emerging Infectious Diseases, 9(11), 1430-1437. https://dx.doi.org/10.3201/eid0911.030339.
  • Hantavirus Pulmonary Syndrome, Southern Chile PDF Version [PDF - 191 KB - 6 pages]
    R. Riquelme et al.
        View Abstract

    We analyzed data from 25 consecutive patients with hantavirus pulmonary syndrome (HPS) admitted to the Puerto Montt and Osorno Regional Hospitals, southern Chile, from 1997 to 2001, emphasizing epidemiologic, clinical, radiographic, treatment, and laboratory aspects. Hemorrhage was frequent (64%), and 48% of patients showed alterations in renal function. Ten patients died (40%). We identified three groups of patients, which included the following: 1) those with the least severe form who had prodromic symptoms without pulmonary involvement; 2) those with moderate illness who had interstitial pulmonary infiltrates, usually needed supplemental nasal oxygen, were hemodynamically stable, and had an APACHE II <12 (none of whom died); and 3) those with the severe form who required mechanical ventilation, frequently had hemodynamic instability (93%), experienced a high mortality rate (77%), and had an APACHE II >12. Mild forms of HPS also exist, which are poorly known; the symptoms could be confounded with those of other viral diseases, leading to underdiagnosis.

        Cite This Article
    EID Riquelme R, Riquelme M, Torres A, Rioseco M, Vergara J, Scholz L, et al. Hantavirus Pulmonary Syndrome, Southern Chile. Emerg Infect Dis. 2003;9(11):1438-1443. https://dx.doi.org/10.3201/eid0911.020798
    AMA Riquelme R, Riquelme M, Torres A, et al. Hantavirus Pulmonary Syndrome, Southern Chile. Emerging Infectious Diseases. 2003;9(11):1438-1443. doi:10.3201/eid0911.020798.
    APA Riquelme, R., Riquelme, M., Torres, A., Rioseco, M., Vergara, J., Scholz, L....Carriel, A. (2003). Hantavirus Pulmonary Syndrome, Southern Chile. Emerging Infectious Diseases, 9(11), 1438-1443. https://dx.doi.org/10.3201/eid0911.020798.
  • Triosephosphate Isomerase Gene Characterization and Potential Zoonotic Transmission of Giardia duodenalis PDF Version [PDF - 396 KB - 9 pages]
    I. M. Sulaiman et al.
        View Abstract

    To address the source of infection in humans and public health importance of Giardia duodenalis parasites from animals, nucleotide sequences of the triosephosphate isomerase (TPI) gene were generated for 37 human isolates, 15 dog isolates, 8 muskrat isolates, 7 isolates each from cattle and beavers, and 1 isolate each from a rat and a rabbit. Distinct genotypes were found in humans, cattle, beavers, dogs, muskrats, and rats. TPI and small subunit ribosomal RNA (SSU rRNA) gene sequences of G. microti from muskrats were also generated and analyzed. Phylogenetic analysis on the TPI sequences confirmed the formation of distinct groups. Nevertheless, a major group (assemblage B) contained most of the human and muskrat isolates, all beaver isolates, and the rabbit isolate. These data confirm that G. duodenalis from certain animals can potentially infect humans and should be useful in the detection, differentiation, and taxonomy of Giardia spp.

        Cite This Article
    EID Sulaiman IM, Fayer R, Bern C, Gilman RH, Trout JM, Schantz PM, et al. Triosephosphate Isomerase Gene Characterization and Potential Zoonotic Transmission of Giardia duodenalis. Emerg Infect Dis. 2003;9(11):1444-1452. https://dx.doi.org/10.3201/eid0911.030084
    AMA Sulaiman IM, Fayer R, Bern C, et al. Triosephosphate Isomerase Gene Characterization and Potential Zoonotic Transmission of Giardia duodenalis. Emerging Infectious Diseases. 2003;9(11):1444-1452. doi:10.3201/eid0911.030084.
    APA Sulaiman, I. M., Fayer, R., Bern, C., Gilman, R. H., Trout, J. M., Schantz, P. M....Xiao, L. (2003). Triosephosphate Isomerase Gene Characterization and Potential Zoonotic Transmission of Giardia duodenalis. Emerging Infectious Diseases, 9(11), 1444-1452. https://dx.doi.org/10.3201/eid0911.030084.

Dispatches

  • Severe Acute Respiratory Syndrome–associated Coronavirus Infection PDF Version [PDF - 158 KB - 2 pages]
    P. K. Chan et al.
        View Abstract

    Whether severe acute respiratory syndrome–associated coronavirus (SARS-CoV) infection can be asymptomatic is unclear. We examined the seroprevalence of SARS-CoV among 674 healthcare workers from a hospital in which a SARS outbreak had occurred. A total of 353 (52%) experienced mild self-limiting illnesses, and 321 (48%) were asymptomatic throughout the course of these observations. None of these healthcare workers had antibody to SARS CoV, indicating that subclinical or mild infection attributable to SARS CoV in adults is rare.

        Cite This Article
    EID Chan PK, Ip M, Ng K, Chan RC, Wu A, Lee N, et al. Severe Acute Respiratory Syndrome–associated Coronavirus Infection. Emerg Infect Dis. 2003;9(11):1453-1454. https://dx.doi.org/10.3201/eid0911.030421
    AMA Chan PK, Ip M, Ng K, et al. Severe Acute Respiratory Syndrome–associated Coronavirus Infection. Emerging Infectious Diseases. 2003;9(11):1453-1454. doi:10.3201/eid0911.030421.
    APA Chan, P. K., Ip, M., Ng, K., Chan, R. C., Wu, A., Lee, N....Tam, J. S. (2003). Severe Acute Respiratory Syndrome–associated Coronavirus Infection. Emerging Infectious Diseases, 9(11), 1453-1454. https://dx.doi.org/10.3201/eid0911.030421.
  • Fluoroquinolone Resistance Linked to GyrA, GyrB, and ParC Mutations in Salmonella enterica Typhimurium Isolates in Humans PDF Version [PDF - 212 KB - 2 pages]
    I. Casin et al.
        View Abstract

    We report two cases of infection with clonally unrelated, high-level ciprofloxacin-resistant, β-lactamase–producing strains of Salmonella enterica Typhimurium. Resistance was caused by four topoisomerase mutations, in GyrA, GyrB, and ParC and increased drug efflux. Ciprofloxacin treatment failed in one case. In the second case, reduced susceptibility to third-generation cephalosporins occurred after initial treatment with these drugs and may explain the treatment failure with ceftriaxone.

        Cite This Article
    EID Casin I, Breuil J, Darchis JP, Guelpa C, Collatz E. Fluoroquinolone Resistance Linked to GyrA, GyrB, and ParC Mutations in Salmonella enterica Typhimurium Isolates in Humans. Emerg Infect Dis. 2003;9(11):1455-1457. https://dx.doi.org/10.3201/eid0911.030317
    AMA Casin I, Breuil J, Darchis JP, et al. Fluoroquinolone Resistance Linked to GyrA, GyrB, and ParC Mutations in Salmonella enterica Typhimurium Isolates in Humans. Emerging Infectious Diseases. 2003;9(11):1455-1457. doi:10.3201/eid0911.030317.
    APA Casin, I., Breuil, J., Darchis, J. P., Guelpa, C., & Collatz, E. (2003). Fluoroquinolone Resistance Linked to GyrA, GyrB, and ParC Mutations in Salmonella enterica Typhimurium Isolates in Humans. Emerging Infectious Diseases, 9(11), 1455-1457. https://dx.doi.org/10.3201/eid0911.030317.
  • Cowpox with Severe Generalized Eruption, Finland PDF Version [PDF - 333 KB - 4 pages]
    P. M. Pelkonen et al.
        View Abstract

    Cowpox with a severe, generalized eruption was diagnosed in an atopic 4-year-old girl by electron microscopy, virus isolation, polymerase chain reaction, and immunoglobulin (Ig) M and low-avidity IgG antibodies. The hemagglutinin gene of the isolate clustered with a Russian cowpox virus strain, and more distantly, with other cowpox and vaccinia virus strains. The patient’s dog had orthopoxvirus-specific antibodies, indicating a possible transmission route.

        Cite This Article
    EID Pelkonen PM, Tarvainen K, Hynninen A, Kallio ER, Henttonen H, Palva A, et al. Cowpox with Severe Generalized Eruption, Finland. Emerg Infect Dis. 2003;9(11):1458-1461. https://dx.doi.org/10.3201/eid0911.020814
    AMA Pelkonen PM, Tarvainen K, Hynninen A, et al. Cowpox with Severe Generalized Eruption, Finland. Emerging Infectious Diseases. 2003;9(11):1458-1461. doi:10.3201/eid0911.020814.
    APA Pelkonen, P. M., Tarvainen, K., Hynninen, A., Kallio, E. R., Henttonen, H., Palva, A....Vapalahti, O. (2003). Cowpox with Severe Generalized Eruption, Finland. Emerging Infectious Diseases, 9(11), 1458-1461. https://dx.doi.org/10.3201/eid0911.020814.
  • Pulmonary Tuberculosis due to Mycobacterium bovis in Captive Siberian Tiger PDF Version [PDF - 212 KB - 3 pages]
    Á. Lantos et al.
        View Abstract

    We report the first case of pulmonary tuberculosis caused by Mycobacterium bovis subsp. caprae in a captive Siberian tiger, an endangered feline. The pathogen was isolated from a tracheal aspirate obtained by bronchoscopy. This procedure provided a reliable in vivo diagnostic method in conjunction with conventional and molecular tests for the detection of mycobacteria.

        Cite This Article
    EID Lantos Á, Niemann S, Mezősi L, Sós E, Erdélyi K, Dávid S, et al. Pulmonary Tuberculosis due to Mycobacterium bovis in Captive Siberian Tiger. Emerg Infect Dis. 2003;9(11):1462-1464. https://dx.doi.org/10.3201/eid0911.030297
    AMA Lantos Á, Niemann S, Mezősi L, et al. Pulmonary Tuberculosis due to Mycobacterium bovis in Captive Siberian Tiger. Emerging Infectious Diseases. 2003;9(11):1462-1464. doi:10.3201/eid0911.030297.
    APA Lantos, Á., Niemann, S., Mezősi, L., Sós, E., Erdélyi, K., Dávid, S....Somoskövi, Á. (2003). Pulmonary Tuberculosis due to Mycobacterium bovis in Captive Siberian Tiger. Emerging Infectious Diseases, 9(11), 1462-1464. https://dx.doi.org/10.3201/eid0911.030297.
  • Dengue-1 Virus Isolation during First Dengue Fever Outbreak on Easter Island, Chile PDF Version [PDF - 270 KB - 3 pages]
    C. Perret et al.
        View Abstract

    Dengue virus was detected for the first time in Chile, in an outbreak of dengue fever on Easter Island. The virus was isolated in tissue culture and characterized by reverse transcription–polymerase chain reaction as being dengue type 1.

        Cite This Article
    EID Perret C, Abarca K, Ovalle J, Ferrer P, Godoy P, Olea A, et al. Dengue-1 Virus Isolation during First Dengue Fever Outbreak on Easter Island, Chile. Emerg Infect Dis. 2003;9(11):1465-1467. https://dx.doi.org/10.3201/eid0911.020788
    AMA Perret C, Abarca K, Ovalle J, et al. Dengue-1 Virus Isolation during First Dengue Fever Outbreak on Easter Island, Chile. Emerging Infectious Diseases. 2003;9(11):1465-1467. doi:10.3201/eid0911.020788.
    APA Perret, C., Abarca, K., Ovalle, J., Ferrer, P., Godoy, P., Olea, A....Ferrés, M. (2003). Dengue-1 Virus Isolation during First Dengue Fever Outbreak on Easter Island, Chile. Emerging Infectious Diseases, 9(11), 1465-1467. https://dx.doi.org/10.3201/eid0911.020788.
  • Flow Cytometry and T-Cell Response Monitoring after Smallpox Vaccination PDF Version [PDF - 156 KB - 3 pages]
    F. Poccia et al.
        View Abstract

    Orthopoxvirus zoonosis or smallpox as result of bioterrorism or biological warfare represents a risk for epidemic spread. By monitoring T-cell responses by flow cytometry, we observed a recall response after recent vaccination against smallpox. When the high similarity between the orthopoxviruses is considered, this rapid assay that uses vaccinia antigens could identify recently exposures.

        Cite This Article
    EID Poccia F, Gioia C, Montesano C, Martini F, Horejsh D, Castilletti C, et al. Flow Cytometry and T-Cell Response Monitoring after Smallpox Vaccination. Emerg Infect Dis. 2003;9(11):1468-1470. https://dx.doi.org/10.3201/eid0911.030349
    AMA Poccia F, Gioia C, Montesano C, et al. Flow Cytometry and T-Cell Response Monitoring after Smallpox Vaccination. Emerging Infectious Diseases. 2003;9(11):1468-1470. doi:10.3201/eid0911.030349.
    APA Poccia, F., Gioia, C., Montesano, C., Martini, F., Horejsh, D., Castilletti, C....Ippolito, G. (2003). Flow Cytometry and T-Cell Response Monitoring after Smallpox Vaccination. Emerging Infectious Diseases, 9(11), 1468-1470. https://dx.doi.org/10.3201/eid0911.030349.
  • Shigella dysenteriae Serotype 1, Kolkata, India PDF Version [PDF - 190 KB - 4 pages]
    S. Dutta et al.
        View Abstract

    Since July 2002, bacteriologically confirmed shigellosis cases have increased, and multidrug-resistant Shigella dysenteriae serotype 1 strains have reemerged in patients hospitalized with diarrhea in Kolkata, India. The isolated strains of S. dysenteriae 1 showed resistance to chloramphenicol (80%), ampicillin (100%), tetracycline (100%), co-trimoxazole (100%), nalidixic acid (100%), norfloxacin (100%), and ciprofloxacin (100%). Emergence of fluoroquinolone resistance in S. dysenteriae 1 strains complicated treatment of shigellosis patients. Six strains belonging to provisional serovars of S. dysenteriae were also identified for the first time in patients hospitalized with diarrhea in Kolkata, India.

        Cite This Article
    EID Dutta S, Dutta D, Dutta P, Matsushita S, Bhattacharya SK, Yoshida S, et al. Shigella dysenteriae Serotype 1, Kolkata, India. Emerg Infect Dis. 2003;9(11):1471-1474. https://dx.doi.org/10.3201/eid0911.020652
    AMA Dutta S, Dutta D, Dutta P, et al. Shigella dysenteriae Serotype 1, Kolkata, India. Emerging Infectious Diseases. 2003;9(11):1471-1474. doi:10.3201/eid0911.020652.
    APA Dutta, S., Dutta, D., Dutta, P., Matsushita, S., Bhattacharya, S. K., & Yoshida, S. (2003). Shigella dysenteriae Serotype 1, Kolkata, India. Emerging Infectious Diseases, 9(11), 1471-1474. https://dx.doi.org/10.3201/eid0911.020652.
  • Levofloxacin Treatment Failure in Haemophilus influenzae Pneumonia PDF Version [PDF - 402 KB - 5 pages]
    T. Bastida et al.
        View Abstract

    We describe the first case of failure of oral levofloxacin treatment of community-acquired pneumonia caused by Haemophilus influenzae. The strain showed cross-resistance to fluoroquinolones and carried four mutations in quinolone resistance–determining regions of DNA gyrase and topoisomerase IV genes.

        Cite This Article
    EID Bastida T, Pérez-Vázquez M, Campos J, Cortés-Lletget M, Román F, Tubau F, et al. Levofloxacin Treatment Failure in Haemophilus influenzae Pneumonia. Emerg Infect Dis. 2003;9(11):1475-1479. https://dx.doi.org/10.3201/eid0911.030176
    AMA Bastida T, Pérez-Vázquez M, Campos J, et al. Levofloxacin Treatment Failure in Haemophilus influenzae Pneumonia. Emerging Infectious Diseases. 2003;9(11):1475-1479. doi:10.3201/eid0911.030176.
    APA Bastida, T., Pérez-Vázquez, M., Campos, J., Cortés-Lletget, M., Román, F., Tubau, F....Alonso-Tarrés, C. (2003). Levofloxacin Treatment Failure in Haemophilus influenzae Pneumonia. Emerging Infectious Diseases, 9(11), 1475-1479. https://dx.doi.org/10.3201/eid0911.030176.
  • Fluoroquinolone Susceptibility of Campylobacter Strains, Senegal PDF Version [PDF - 297 KB - 3 pages]
    E. Cardinale et al.
        View Abstract

    To assess fluoroquinolone susceptibility of Campylobacter strains in Senegal, skin samples were collected from 250 chicken carcasses from January 2001 to October 2002. Among 205 isolated Campylobacter strains, 59% and 41% were identified as Campylobacter jejuni and C. coli, respectively; the overall ciprofloxacin-resistance rate was 34%.

        Cite This Article
    EID Cardinale E, Dromigny J, Tall F, Ndiaye M, Konte M, Perrier-Gros-Claude J, et al. Fluoroquinolone Susceptibility of Campylobacter Strains, Senegal. Emerg Infect Dis. 2003;9(11):1479-1481. https://dx.doi.org/10.3201/eid0911.020693
    AMA Cardinale E, Dromigny J, Tall F, et al. Fluoroquinolone Susceptibility of Campylobacter Strains, Senegal. Emerging Infectious Diseases. 2003;9(11):1479-1481. doi:10.3201/eid0911.020693.
    APA Cardinale, E., Dromigny, J., Tall, F., Ndiaye, M., Konte, M., & Perrier-Gros-Claude, J. (2003). Fluoroquinolone Susceptibility of Campylobacter Strains, Senegal. Emerging Infectious Diseases, 9(11), 1479-1481. https://dx.doi.org/10.3201/eid0911.020693.
  • Fluoroquinolone Resistance in Campylobacter Absent from Isolates, Australia
    L. Unicomb et al.
        View Abstract

    Fluoroquinolone resistance was detected in 12 of 370 Australian human Campylobacter isolates; 10 of these were travel-associated, and for 2 isolates travel status was unknown. No resistance was found in isolates known to be locally acquired. In Australia, fluoroquinolones have not been licensed for use in food production animals, a policy that may have relevance for countries with fluoroquinolone-resistant Campylobacter.

        Cite This Article
    EID Unicomb L, Ferguson J, Riley T, Collignon P. Fluoroquinolone Resistance in Campylobacter Absent from Isolates, Australia. Emerg Infect Dis. 2003;9(11):1482-1483. https://dx.doi.org/10.3201/eid0911.030336
    AMA Unicomb L, Ferguson J, Riley T, et al. Fluoroquinolone Resistance in Campylobacter Absent from Isolates, Australia. Emerging Infectious Diseases. 2003;9(11):1482-1483. doi:10.3201/eid0911.030336.
    APA Unicomb, L., Ferguson, J., Riley, T., & Collignon, P. (2003). Fluoroquinolone Resistance in Campylobacter Absent from Isolates, Australia. Emerging Infectious Diseases, 9(11), 1482-1483. https://dx.doi.org/10.3201/eid0911.030336.
  • Cutaneous Melioidosis and Necrotizing Fasciitis Caused by Burkholderia pseudomallei PDF Version [PDF - 162 KB - 2 pages]
    Y. Wang et al.
        View Abstract

    In areas where melioidosis is endemic, stress on the healthcare system is substantial. Because clinical manifestations are protean, the illness is difficult to diagnose, and cutaneous Burkholderia pseudomallei infections can progress to necrotizing fasciitis. While it is an uncommon complication of cutaneous melioidosis, necrotizing fasciitis is potentially fatal and requires successful management, including early diagnosis, appropriate antibiotics selection, and operative débridement.

        Cite This Article
    EID Wang Y, Wong C, Kurup A. Cutaneous Melioidosis and Necrotizing Fasciitis Caused by Burkholderia pseudomallei. Emerg Infect Dis. 2003;9(11):1484-1485. https://dx.doi.org/10.3201/eid0911.030370
    AMA Wang Y, Wong C, Kurup A. Cutaneous Melioidosis and Necrotizing Fasciitis Caused by Burkholderia pseudomallei. Emerging Infectious Diseases. 2003;9(11):1484-1485. doi:10.3201/eid0911.030370.
    APA Wang, Y., Wong, C., & Kurup, A. (2003). Cutaneous Melioidosis and Necrotizing Fasciitis Caused by Burkholderia pseudomallei. Emerging Infectious Diseases, 9(11), 1484-1485. https://dx.doi.org/10.3201/eid0911.030370.
  • Polymerase Chain Reaction Assay and Bacterial Meningitis Surveillance in Remote Areas, Niger PDF Version [PDF - 217 KB - 3 pages]
    F. Sidikou et al.
        View Abstract

    To compensate for the lack of laboratories in remote areas, the national reference laboratory for meningitis in Niger used polymerase chain reaction (PCR) to enhance the surveillance of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. PCR effectively documented the wide geographic spread of N. meningitidis serogroup W135.

        Cite This Article
    EID Sidikou F, Djibo S, Taha MK, Alonso JM, Djibo A, Kairo KK, et al. Polymerase Chain Reaction Assay and Bacterial Meningitis Surveillance in Remote Areas, Niger. Emerg Infect Dis. 2003;9(11):1486-1488. https://dx.doi.org/10.3201/eid0911.030462
    AMA Sidikou F, Djibo S, Taha MK, et al. Polymerase Chain Reaction Assay and Bacterial Meningitis Surveillance in Remote Areas, Niger. Emerging Infectious Diseases. 2003;9(11):1486-1488. doi:10.3201/eid0911.030462.
    APA Sidikou, F., Djibo, S., Taha, M. K., Alonso, J. M., Djibo, A., Kairo, K. K....Boisier, P. (2003). Polymerase Chain Reaction Assay and Bacterial Meningitis Surveillance in Remote Areas, Niger. Emerging Infectious Diseases, 9(11), 1486-1488. https://dx.doi.org/10.3201/eid0911.030462.

Commentaries

  • Frequency of Revaccination against Smallpox PDF Version [PDF - 132 KB - 2 pages]
    S. Baron et al.
            Cite This Article
    EID Baron S, Pan J, Poast J. Frequency of Revaccination against Smallpox. Emerg Infect Dis. 2003;9(11):1489-1490. https://dx.doi.org/10.3201/eid0911.020820
    AMA Baron S, Pan J, Poast J. Frequency of Revaccination against Smallpox. Emerging Infectious Diseases. 2003;9(11):1489-1490. doi:10.3201/eid0911.020820.
    APA Baron, S., Pan, J., & Poast, J. (2003). Frequency of Revaccination against Smallpox. Emerging Infectious Diseases, 9(11), 1489-1490. https://dx.doi.org/10.3201/eid0911.020820.

Letters

  • Asymptomatic Severe Acute Respiratory Syndrome–associated Coronavirus Infection PDF Version [PDF - 127 KB - 2 pages]
    H. K. Lee et al.
            Cite This Article
    EID Lee HK, Tso EY, Chau TN, Tsang OT, Choi W, Lai TS, et al. Asymptomatic Severe Acute Respiratory Syndrome–associated Coronavirus Infection. Emerg Infect Dis. 2003;9(11):1491-1492. https://dx.doi.org/10.3201/eid0911.030401
    AMA Lee HK, Tso EY, Chau TN, et al. Asymptomatic Severe Acute Respiratory Syndrome–associated Coronavirus Infection. Emerging Infectious Diseases. 2003;9(11):1491-1492. doi:10.3201/eid0911.030401.
    APA Lee, H. K., Tso, E. Y., Chau, T. N., Tsang, O. T., Choi, W., & Lai, T. S. (2003). Asymptomatic Severe Acute Respiratory Syndrome–associated Coronavirus Infection. Emerging Infectious Diseases, 9(11), 1491-1492. https://dx.doi.org/10.3201/eid0911.030401.
  • Hepatitis C Antibodies among Blood Donors, Senegal, 2001 PDF Version [PDF - 156 KB - 2 pages]
    J. Etard et al.
            Cite This Article
    EID Etard J, Colbachini P, Dromigny J, Perrier-Gros-Claude J. Hepatitis C Antibodies among Blood Donors, Senegal, 2001. Emerg Infect Dis. 2003;9(11):1492-1493. https://dx.doi.org/10.3201/eid0911.030191
    AMA Etard J, Colbachini P, Dromigny J, et al. Hepatitis C Antibodies among Blood Donors, Senegal, 2001. Emerging Infectious Diseases. 2003;9(11):1492-1493. doi:10.3201/eid0911.030191.
    APA Etard, J., Colbachini, P., Dromigny, J., & Perrier-Gros-Claude, J. (2003). Hepatitis C Antibodies among Blood Donors, Senegal, 2001. Emerging Infectious Diseases, 9(11), 1492-1493. https://dx.doi.org/10.3201/eid0911.030191.
  • When Is a Reservoir Not a Reservoir? PDF Version [PDF - 157 KB - 2 pages]
    R. Ashford
            Cite This Article
    EID Ashford R. When Is a Reservoir Not a Reservoir?. Emerg Infect Dis. 2003;9(11):1495-1496. https://dx.doi.org/10.3201/eid0911.030088
    AMA Ashford R. When Is a Reservoir Not a Reservoir?. Emerging Infectious Diseases. 2003;9(11):1495-1496. doi:10.3201/eid0911.030088.
    APA Ashford, R. (2003). When Is a Reservoir Not a Reservoir?. Emerging Infectious Diseases, 9(11), 1495-1496. https://dx.doi.org/10.3201/eid0911.030088.
  • Invasive Mycobacterium marinum Infections PDF Version [PDF - 163 KB - 3 pages]
    T. Lahey
            Cite This Article
    EID Lahey T. Invasive Mycobacterium marinum Infections. Emerg Infect Dis. 2003;9(11):1496-1498. https://dx.doi.org/10.3201/eid0911.030192
    AMA Lahey T. Invasive Mycobacterium marinum Infections. Emerging Infectious Diseases. 2003;9(11):1496-1498. doi:10.3201/eid0911.030192.
    APA Lahey, T. (2003). Invasive Mycobacterium marinum Infections. Emerging Infectious Diseases, 9(11), 1496-1498. https://dx.doi.org/10.3201/eid0911.030192.
  • Rickettsialpox in Turkey PDF Version [PDF - 151 KB - 2 pages]
    M. K. Ozturk et al.
            Cite This Article
    EID Ozturk MK, Gunes T, Kose M, Coker C, Radulovic S. Rickettsialpox in Turkey. Emerg Infect Dis. 2003;9(11):1498-1499. https://dx.doi.org/10.3201/eid0911.030224
    AMA Ozturk MK, Gunes T, Kose M, et al. Rickettsialpox in Turkey. Emerging Infectious Diseases. 2003;9(11):1498-1499. doi:10.3201/eid0911.030224.
    APA Ozturk, M. K., Gunes, T., Kose, M., Coker, C., & Radulovic, S. (2003). Rickettsialpox in Turkey. Emerging Infectious Diseases, 9(11), 1498-1499. https://dx.doi.org/10.3201/eid0911.030224.
  • Human Granulocytic Ehrlichiosis in Estonia PDF Version [PDF - 196 KB - 2 pages]
    T. Prükk et al.
            Cite This Article
    EID Prükk T, Ainsalu K, Laja E, Aigro A. Human Granulocytic Ehrlichiosis in Estonia. Emerg Infect Dis. 2003;9(11):1499-1500. https://dx.doi.org/10.3201/eid0911.030480
    AMA Prükk T, Ainsalu K, Laja E, et al. Human Granulocytic Ehrlichiosis in Estonia. Emerging Infectious Diseases. 2003;9(11):1499-1500. doi:10.3201/eid0911.030480.
    APA Prükk, T., Ainsalu, K., Laja, E., & Aigro, A. (2003). Human Granulocytic Ehrlichiosis in Estonia. Emerging Infectious Diseases, 9(11), 1499-1500. https://dx.doi.org/10.3201/eid0911.030480.
  • Prosthetic Valve Endocarditis due to Kytococcus schroeteri PDF Version [PDF - 163 KB - 3 pages]
    K. Becker et al.
            Cite This Article
    EID Becker K, Wüllenweber J, Odenthal H, Moeller M, Schumann P, Peters G, et al. Prosthetic Valve Endocarditis due to Kytococcus schroeteri. Emerg Infect Dis. 2003;9(11):1493-1495. https://dx.doi.org/10.3201/eid0911.020683
    AMA Becker K, Wüllenweber J, Odenthal H, et al. Prosthetic Valve Endocarditis due to Kytococcus schroeteri. Emerging Infectious Diseases. 2003;9(11):1493-1495. doi:10.3201/eid0911.020683.
    APA Becker, K., Wüllenweber, J., Odenthal, H., Moeller, M., Schumann, P., Peters, G....von Eiff, C. (2003). Prosthetic Valve Endocarditis due to Kytococcus schroeteri. Emerging Infectious Diseases, 9(11), 1493-1495. https://dx.doi.org/10.3201/eid0911.020683.

Books and Media

  • Atlas of Travel Medicine and Health PDF Version [PDF - 140 KB - 1 page]
    L. H. Chen
            Cite This Article
    EID Chen LH. Atlas of Travel Medicine and Health. Emerg Infect Dis. 2003;9(11):1501. https://dx.doi.org/10.3201/eid0911.030503
    AMA Chen LH. Atlas of Travel Medicine and Health. Emerging Infectious Diseases. 2003;9(11):1501. doi:10.3201/eid0911.030503.
    APA Chen, L. H. (2003). Atlas of Travel Medicine and Health. Emerging Infectious Diseases, 9(11), 1501. https://dx.doi.org/10.3201/eid0911.030503.

About the Cover

  • Francisco José de Goya y Lucientes (1746–1828). Cat Fight (1786–1788). PDF Version [PDF - 320 KB - 2 pages]
    P. Potter
            Cite This Article
    EID Potter P. Francisco José de Goya y Lucientes (1746–1828). Cat Fight (1786–1788).. Emerg Infect Dis. 2003;9(11):1506-1507. https://dx.doi.org/10.3201/eid0911.AC0911
    AMA Potter P. Francisco José de Goya y Lucientes (1746–1828). Cat Fight (1786–1788).. Emerging Infectious Diseases. 2003;9(11):1506-1507. doi:10.3201/eid0911.AC0911.
    APA Potter, P. (2003). Francisco José de Goya y Lucientes (1746–1828). Cat Fight (1786–1788).. Emerging Infectious Diseases, 9(11), 1506-1507. https://dx.doi.org/10.3201/eid0911.AC0911.

News and Notes

  • Northern Ireland Food Safety Night PDF Version [PDF - 195 KB - 1 page]
    J. E. Moore
            Cite This Article
    EID Moore JE. Northern Ireland Food Safety Night. Emerg Infect Dis. 2003;9(11):1502. https://dx.doi.org/10.3201/eid0911.030491
    AMA Moore JE. Northern Ireland Food Safety Night. Emerging Infectious Diseases. 2003;9(11):1502. doi:10.3201/eid0911.030491.
    APA Moore, J. E. (2003). Northern Ireland Food Safety Night. Emerging Infectious Diseases, 9(11), 1502. https://dx.doi.org/10.3201/eid0911.030491.
  • W135 Meningococcal Disease in Africa PDF Version [PDF - 167 KB - 2 pages]
    A. J. Pollard et al.
            Cite This Article
    EID Pollard AJ, Santamaria M, Maiden MC. W135 Meningococcal Disease in Africa. Emerg Infect Dis. 2003;9(11):1503-1504. https://dx.doi.org/10.3201/eid0911.020727
    AMA Pollard AJ, Santamaria M, Maiden MC. W135 Meningococcal Disease in Africa. Emerging Infectious Diseases. 2003;9(11):1503-1504. doi:10.3201/eid0911.020727.
    APA Pollard, A. J., Santamaria, M., & Maiden, M. C. (2003). W135 Meningococcal Disease in Africa. Emerging Infectious Diseases, 9(11), 1503-1504. https://dx.doi.org/10.3201/eid0911.020727.
TOP